The market for pancreatic and biliary stents is set to increase during the next few years. According to GlobalData’s recent report on pancreatic and biliary stents, the market value for these stents was estimated to be $203.6m in 2016 and is expected to reach $293.9m in 2023.
Primary growth factors include increased disease rates and the continuing development of stenting technology. Obstructions of the biliary and pancreatic ducts caused by cancer are often relieved by stenting. Other indications include presence of stones in these ducts.
Emerging stent technology is another factor that is expected to positively influence the growth of this market. What began as plastic stent technology has now evolved to metal stents, which are associated with staying open longer and reduced migration compared to the plastic stents.
Major players include Boston Scientific and Cook Medical, with both companies having extensive product lines and strong international presences. Other top players include Taewoong Medical, ELLA-CS, and EndoFlex.
